- Home
- WLAC vs PYXS Comparison
WLAC vs PYXS Comparison
Compare WLAC & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$1.30
Company Overview
Basic Information| Metric | WLAC | PYXS |
|---|---|---|
| Founded | 2024 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 219.1M | 243.5M |
| IPO Year | 2024 | 2021 |
Fundamental Metrics
Financial Performance| Metric | WLAC | PYXS |
|---|---|---|
| Price | $12.18 | $1.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $17.00 | $7.50 |
| AVG Volume (30 Days) | 202.4K | ★ 1.2M |
| Earning Date | 01-01-0001 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,820,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $844.52 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.80 | $0.83 |
| 52 Week High | $15.19 | $5.55 |
Technical Indicators
Market Signals| Indicator | WLAC | PYXS |
|---|---|---|
| Relative Strength Index (RSI) | 56.71 | 20.88 |
| Support Level | $11.21 | $4.10 |
| Resistance Level | $12.35 | $4.58 |
| Average True Range (ATR) | 0.40 | 0.40 |
| MACD | 0.07 | -0.36 |
| Stochastic Oscillator | 84.65 | 2.07 |
Price Performance
Historical Comparison WLAC
PYXS
About WLAC Willow Lane Acquisition Corp. Class A Ordinary Shares
Willow Lane Acquisition Corp is a blank check company.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.